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Abstract
Reperfusion injury following myocardial infarction (MI) increases infarct size (IS) and deteriorates cardiac function. Cardioprotective strategies
in large animal MI models often failed in clinical trials, suggesting translational failure. Experimentally, MI is induced artificially and the effect of
the experimental procedures may influence outcome and thus clinical applicability. The aim of this study was to investigate if invasive surgery,
as in the common open chest MI model affects IS and cardiac function. Twenty female landrace pigs were subjected to MI by transluminal bal-
loon occlusion. In 10 of 20 pigs, balloon occlusion was preceded by invasive surgery (medial sternotomy). After 72 hrs, pigs were subjected to
echocardiography and Evans blue/triphenyl tetrazoliumchloride double staining to determine IS and area at risk. Quantification of IS showed a
significant IS reduction in the open chest group compared to the closed chest group (IS versus area at risk: 50.9  5.4% versus 69.9  3.4%,
P = 0.007). End systolic LV volume and LV ejection fraction measured by echocardiography at follow-up differed significantly between both
groups (51  5 ml versus 65  3 ml, P = 0.033; 47.5  2.6% versus 38.8  1.2%, P = 0.005). The inflammatory response in the damaged
myocardium did not differ between groups. This study indicates that invasive surgery reduces IS and preserves cardiac function in a porcine MI
model. Future studies need to elucidate the effect of infarct induction technique on the efficacy of pharmacological therapies in large animal car-
dioprotection studies.
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Introduction
Myocardial infarction (MI) and heart failure (HF) remain the most
important cardiovascular causes of death worldwide [1, 2]. Because
of improved medical care and revascularization therapy, survival after
MI has increased considerably during the past decades [3, 4]. This
improved survival increases the risk to develop HF as patients survive
with a severely deteriorated cardiac function [1]. To prevent progres-
sion into HF and preserve cardiac function post-MI, investigators aim
to modulate the predominant mechanisms involved in MI and post-
MI healing (reperfusion injury, adverse cardiac remodelling) [5, 6].
Before clinical testing of therapeutics is considered, thorough
testing in clinically relevant animal models should be performed [7].
In this perspective, large animal MI models are required to confirm
findings from studies performed in small animals, as the development
of tissue damage post-MI differs in small animals compared to larger
mammals [8, 9]. Additionally, large animal models show great simi-
larity with humans regarding hemodynamics, cardiac anatomy (coro-
nary) pharmacokinetics and –dynamics [10, 11]. Large animal
models also allow the use of clinical treatment regimens and adminis-
tration routes along with identical function-related read-outs [12, 13].
Despite these advantages, many compounds that were successful in
large animal models eventually failed in clinical trials, suggesting opti-
mization of experimental protocols remains necessary [14].
Numerous methods of inducing myocardial ischemia in large ani-
mals have been proposed. Despite abundant variations of ischemia
induction, there are two main approaches [11]. The first requires
invasive surgery, including lateral or medial sternotomy, to reach the
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coronary arteries and induce ischemia from an external approach.
The second method mimics percutaneous coronary intervention and
follows a transluminal approach. The invasive method induces bone
trauma and alters intra-thoracic pressure, possibly influencing cardiac
physiology whereas trauma induced by the minimal-invasive method
is much less extensive [11–13, 15].
Previous reports from small and large animal studies indicate
that abdominal skin injury prior to MI limits infarct size (IS) after
cardiac ischemia [16, 17]. It has also been established that tissue
damage, as can be observed during MI and traumatic injury,
attracts circulating leucocytes to the site of injury [18–20]. Further-
more, surgery can cause a decreased ex vivo responsiveness of
leucocytes [21, 22]. As additional injury is known to influence
myocardial IS and temporary immune suppression occurs in
patients undergoing surgery, we hypothesized that medial ster-
notomy required for external MI induction decreases myocardial IS
and preserves cardiac function post-MI. Additionally, we aimed to
determine if sternotomy influences the local inflammatory response
in the myocardium. This may have significant implications for the
interpretation of experimental studies on therapeutic compounds
tested in either model.
Material and methods
All animal experiments were approved by the institutional animal welfare
committee of the University Medical Center Utrecht and were executed
conforming to the ‘Guide for the Care and Use of Laboratory Animals’.
Twenty female landrace pigs were evaluated in this study (Van Beek,
Lelystad, The Netherlands). Pigs (69.8  1.0 kg) were subjected to MI
by transluminal balloon occlusion of the left anterior descending artery
(LAD) followed by invasive pressure-volume measurements; 3D-
Echocardiography and Evans blue/triphenyl tetrazoliumchloride (TTC)
double staining to determine IS and area at risk (AAR) at 72 hrs follow-
up. In 10 of 20 pigs, balloon-occlusion was preceded by medial ster-
notomy.
Surgical procedure
Pre-treatment and anaesthesia protocols have been described elsewhere
[12, 23]. In short, all animals were pre-treated with amiodaron for
10 days (1200 mg loading dose, 800 mg/day maintenance), clopidogrel
for 3 days (75 mg/day) and acetylsalicylic acid for 1 day (320 mg load-
ing dose, 80 mg/day maintenance). All medication was continued until
the end of the study. To prevent unnecessary stress and discomfort,
animals were anaesthetized with an intramuscular injection of 10 mg/kg
ketamine, 0.4 mg/kg midazolam and 0.014 mg/kg atropine. Venous
access was obtained by insertion of an 18G cannula in the ear vein for
intravenous administration of 5 mg/kg sodiumthiopental. Depth of
anaesthesia was then determined by checking eyelid reflex, response to
skin stimulus and laryngeal reflex followed by intubation with an endo-
tracheal tube and balloon-ventilation. Pigs were transported to the oper-
ating room where anaesthesia was maintained by intravenous infusion
of 0.5 mg/kg/hr midazolam, 2.5 lg/kg/hr sufentanyl and 0.1 mg/kg/hr
pancuronium. Pigs were mechanically ventilated and arterial blood
pressure and heart rate were checked when performing surgical actions
to determine the depth of anaesthesia. Pre-operatively, animals received
a fentanyl patch (25 lg/hr). Arterial access was obtained by introduc-
tion of an 8F sheath into the carotid artery after surgical exposure.
Pigs were then randomly allocated to either an open or closed chest
procedure.
Closed chest group
After arterial and venous access were obtained, the closed chest ani-
mals were left untouched for 20 min. This corresponds to the time
required to perform the sternotomy in the open chest group. A coro-
nary angiogram of the left coronary tree was acquired using an 8F
JL4 guiding catheter (Boston Scientific, Natick, MA, USA). An ade-
quately sized balloon was placed distal to the second diagonal branch
and inflated for 75 min. After reperfusion, a catheter was temporarily
placed in the coronary sinus via an introducer sheath in the jugular
vein to draw blood 60 min. after reperfusion. Animals were observed
for 3 hrs post-reperfusion and blood samples were drawn at various
time-points. A dwelling catheter was placed in the jugular vein in 3
pigs of each experimental group to allow additional venous blood sam-
pling at 4 and 8 hrs reperfusion. The surgical wound was closed and
animals were weaned from anaesthesia. Animals were defibrillated in
case of ventricular fibrillation (VF). Body temperature was kept con-
stant between 37.0 and 38.5°C throughout the experiment. Heart rate
and arterial blood pressure were measured continuously and docu-
mented every 30 min.
Open chest group
The open chest group was treated identical to the closed chest group
with the exception that in the 20 min. period after the insertion of the
arterial and venous sheaths, a medial sternotomy was performed. After
performing the myocardial ischemia/reperfusion protocol as described
above, the sternum and the surgical wound were closed and animals
were weaned from anaesthesia.
Pressure–volume measurements
Pressure–volume measurements were performed as described recently
[23, 24]. In short, animals were again anaesthetized 72 hrs after infarct
induction. Arterial access was obtained by introducing an 8F sheath into
the carotid artery. A 7F tetra-polar admittance catheter (7.0 VSL Pigtail/
no lumen; Transonic Scisense, London, ON, Canada) was inserted into
the left ventricle (LV) through the sheath in the carotid artery under flu-
oroscopic guidance.
Echocardiography
Three-dimensional echocardiography was performed as described
before [12, 24, 25]. In short, an X3-1 transducer on an iE33 ultrasound
device (Philips, Eindhoven, The Netherlands) was used 72 hrs after
reperfusion. Immediately after PV measurements, a medial (re)ster-
notomy was performed and a gel-filled flexible sleeve was placed
directly on the apex of the heart. The depth and sector size were
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adjusted to fit the complete ventricle. The images were analysed offline
using QLab 10.1 (Philips, Eindhoven, The Netherlands) (3DQ advanced)
analysis software.
Area at risk and infarct size
Before exsanguination, the leukocyte adhesion deficiency (LAD) was
externally ligated at the exact site of balloon occlusion. The LV was
punctured with a sterile needle attached to a 50 ml syringe filled with
2% Evans blue dissolved in 50 ml 0.9% NaCl. The aortic root was
clamped distal to the origin of the coronary arteries. Evans blue was
infused at a rate of 10 ml/sec. Animals were then killed by exsanguina-
tion under anaesthesia. The heart was excised and the LV was cut into
5 equal slices from apex to base. Slices were incubated in 1% TTC
(Sigma-Aldrich Chemicals, Zwijndrecht, The Netherlands) in 37°C 0.9%
NaCl for 10 min. to discriminate between infarct tissue and viable myo-
cardium. After incubation, photographs of the slices were taken at the
remote area, AAR and infarcted tissue were quantified using ImageJ
software (NIH, Bethesda, MD, USA). Following quantification, infarcted
tissue, tissue from the border zone and tissue from the remote area
were collected and either conserved in 4% formaldehyde for histological
quantification of neutrophils, or snap frozen in liquid nitrogen for cyto-
kine measurements.
Neutrophil numbers, macrophage numbers and
inflammatory parameters
Circulating leucocyte numbers from blood drawn at multiple time-points
after reperfusion were measured by whole-blood analysis using an auto-
mated haematological cell-counter (Cell-Dyn Sapphire; Abbott, Santa
Clara, CA, USA). The Cell-Dyn Sapphire is a routine haematology ana-
lyzer, which uses spectophotometry, electrical impedance and laser light
scattering to classify blood cells (platelets, erythrocytes and leuko-
cytes).
Neutrophil numbers, macrophage numbers and active caspase-3 pos-
itive cells in myocardial tissue were measured in paraffin-embedded his-
tological biopsies that were conserved in 4% formaldehyde for at least
7 days. Histological samples were cut into 5 lm sections using a
microtome and sections were deparaffinized. To assess neutrophil num-
bers, sections were incubated with a porcine-specific monoclonal
mouse anti-pig antibody against porcine neutrophils (Clone PM1; BMA
Biomedicals, Augst, Switzerland) for 60 min. followed by incubation
with Brightvision Poly-AP-antimouse (ImmunoLogic, Duiven, The
Netherlands) for 30 min. To determine macrophage numbers, sections
were incubated with a monoclonal mouse anti-pig CD107a antibody
(Serotec, Raleigh, NC, USA) followed by incubation with the same sec-
ondary antibody. Caspase-3 positive cells were assessed using a puri-
fied rabbit anti-active caspase-3 antibody (BD Pharmigen, San Diego,
CA, USA) followed by incubation with Brightvision Poly-AP-anti-rabbit
(Immunologic) for 30 min. For microscopic visualization, incubation
with liquid permanent red (DAKO, Heverlee, Belgium) for 10 min. was
performed. For every animal, 10 random pictures were made at 2009
magnification and quantified using CellSens software (Center Valley, PA,
USA).
Malondialdehyde (MDA) is a marker of lipid peroxidation and
oxidative stress and was measured to determine if sternotomy induced
less oxidative stress in the myocardium during reperfusion. Malondi-
aldehyde was measured from plasma obtained by centrifugation at
1850 9 g for 10 min. at 4°C. To quantify MDA, we used a lipid
peroxidation – MDA – kit (Abcam, Cambridge, MA, USA) according to
the manufacturer’s instructions.
To assess the inflammatory response in the myocardium, the expres-
sion of 9 different cytokines [interleukin (IL)-1b, IL-4, IL-6, IL-8, IL-10,
IL-12p40, tumour necrosis factor (TNF)-a, interferon (IFN)-a and IFN-c]
was measured using a luminex immunoassay (ProcartaTM Multiplex;
eBioscience, San Diego, CA, USA) according to the manufacturer’s
instructions.
Western blotting
High molecular weight kininogen (HMWK) was measured as a proxy of
bradykinin release. Plasma samples drawn at baseline and 15 min.
reperfusion were diluted 20 times in reducing sample buffer (15.5%
Glycerol, 96.8 mM Tris-HCL, 3.1% SDS, 0.003% bromophenol blue,
25 mM Dithiothreitol) and incubated for 10 min. at 95°C. Samples were
separated on a 4–12% Bis-Tris gel at 165 V for 65 min. in 3-(N-
morpholino)propanesulfonic acid buffer. Proteins were transferred onto
Immobilon-FL membranes at 125 V for 60 min. in blotting buffer
(14.4 g/l glycine, 3.03 g/l Tris-HCL, 20% ethanol) and blocked with
blocking buffer (0.59 Odyssey blocking reagent in Tris-buffered saline)
for 1 hr at RT. High molecular weight kininogen was detected by over-
night incubation at 4°C with polyclonal affinity purified sheep anti-hu-
man HMWK antibody (Affinity Biologicals Inc., Ancaster, ON, Canada).
Blots were washed with 0.005% TBS-Tween (TBST), and primary anti-
bodies were detected with Alexa Fluor 680 Donkey Anti-Sheep IgG
(1:7500 in blocking buffer; Life Technologies, Carlsbad, CA, USA). Blots
were extensively washed with TBST, followed by washing with water
and analysed on a near infra-red Odyssey scanner (LI-COR Biotechnol-
ogy, Lincoln, NE, USA).
Statistical analysis
All data are expressed as mean  SE unless stated otherwise. Differ-
ences in mortality were tested using a Fisher’s exact test. Myocardial
IS, LV ejection fraction (LVEF) and all other outcome were compared
using a Student’s t-test for unrelated measurements. All statistical anal-
yses were performed in SPSS statistics version 20.0 (IBM software,
Armonk, NY, USA). A two-sided P-value of <0.05 was regarded statisti-
cally significant in all analyses.
Results
Mortality and hemodynamics
Twenty pigs were subjected to 75 min. myocardial ischemia-reperfu-
sion injury. Four pigs died before the follow-up period (1 in the closed
chest and 3 in the open chest group, all because of the persistent VF
during cardiac ischemia). Fisher’s exact testing showed that this dif-
ference was statistically not significant (P = 0.292). This allowed a
comparison of nine animals in the closed chest and seven animals in
the open chest group.
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During the 3-hr observation period post-MI, heart rate did not sig-
nificantly differ between both groups (Fig. 1A). However, from the
onset of ischemia onwards, mean arterial pressure (MAP) in the open
chest group was significantly lower than in the closed chest group
(Fig. 1B). This difference in MAP reached its peak at 60 min. post-oc-
clusion (71 mmHg versus 107 mmHg, P = 0.006) and gradually
returned to equal levels by the end of the observational period of
180 min. (85 mmHg versus 84 mmHg, P = ns).
Myocardial infarct size and cardiac function
Cardiac function and myocardial IS were determined after a follow-
up period of 72 hrs. Figure 2A shows representative pictures of the
remote area (blue), AAR (red) and infarcted myocardium (white).
Quantification of the AAR showed a similar AAR as a percentage of
the LV in the open chest and closed chest group (19.1  3.0%
versus 19.4  1.3%, P = ns; Fig. 2B). Quantification of IS showed
a significant reduction in the open chest group compared to the
closed chest group when measured as percentage of the AAR
(50.9  5.4% versus 69.9  3.4%, P = 0.007; Fig. 2C) and using
the total LV as reference (9.2  1.3% versus 13.6  1.2%,
P = 0.024; Fig. 2D).
Cardiac function also differed between the two experimental
groups. While end diastolic volume did not differ between the open
chest and the closed chest group (99  7 ml versus 106  4 ml,
P = ns), end systolic volume (51  5 ml versus 65  3 ml, P =
0.033) and LVEF (47.5  2.6% versus 38.8  1.2%, P = 0.005)
differed significantly between both groups (Fig. 3A–C). Interestingly,
the load-dependent rate of pressure increase (dPdt-Max) during
systole was lower in the open chest group than in the closed chest
group despite a smaller IS and better global cardiac function
(886  80 mmHg/sec. versus 1373  87 mmHg/sec., P = 0.002).
The load-dependent rate of pressure decrease (dPdt-Min) during
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Fig. 1 Hemodynamic parameters were recorded every 30 min. during the experiments. (A) Heart rate did not differ significantly from the onset of
ischemia to 180 min. post-reperfusion. (B) A significant decrease in MAP was observed at multiple time-points during ischemia and reperfusion,
peaking at 60 min. of ischemia. Bpm: beats per minute; MAP: mean arterial pressure, *P < 0.05.
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Fig. 2 After 72 hrs of reperfusion, the
AAR and IS were determined. (A) Repre-
sentative pictures of an apical slice of a
pig that was subjected to MI without (CC)
and with sternotomy (OC). (B) The AAR
as a percentage of the total LV was equal
between the closed chest and open chest
group. (C) The IS as a percentage of the
AAR differed significantly between the
closed chest and open chest group. (D)
The IS as a percentage of the total LV dif-
fered significantly between the closed
chest and open chest group. CC: closed
chest; OC: open chest; AAR: area at risk;
IS: infarct size; LV: left ventricle,
*P < 0.05.
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diastole was less negative in the open chest group compared to
the closed chest group (964  78 mmHg/sec. versus 1273
 77 mmHg/sec., P = 0.018; Fig. 3D and E). Troponin was
measured 2 hrs after reperfusion and was significantly lower in the
open chest compared to the closed chest group (251  44 ng/ml
versus 1256  281 ng/ml, P = 0.008; Fig. 4A).
Inflammatory markers, oxidative stress and
bradykinin release
To determine if the two models differed in the systemic inflammatory
response post-MI, we measured systemic leucocyte numbers up to
2 hrs reperfusion. As no differences in leucocyte numbers were
detected during ischemia and the first 2 hrs of reperfusion (Fig. 4B
and C), we also measured systemic leucocyte numbers 4 and 8 hrs
post-reperfusion in a subset of pigs (n = 3 in each group). In the
open chest group, circulating leucocyte numbers were significantly
higher at 8 hrs reperfusion in the open chest compared to the closed
chest group (31.6  0.2 9 106 versus 23.1  2.0 9 106 leuco-
cytes/ml, P = 0.014; Fig. 4B). Neutrophil numbers were also signifi-
cantly increased in this group (25.6  0.1 9 106 neutrophils/ml
versus 18.1  1.2 9 106 neutrophils/ml, P = 0.040; Fig. 4C) 8 hrs
post-reperfusion. Other leucocyte subtypes did not differ significantly
between both groups at any time-point (data not shown). As inflam-
matory cells are an important source of free radical scavengers at the
site of injury, MDA, a marker of oxidative stress, was measured in
blood directly drawn from the coronary sinus 1 hr after reperfusion in
both groups. However, there was no significant difference in MDA
levels between both groups (MDA concentration: 483  55 nmol/ml
versus 465  45 nmol/ml, P = ns; Fig. 4D).
To investigate potential differences in the severity of the local
immune response, we measured a variety of cytokines known to
play a role in the inflammatory phase post-MI. We did not observe
any significant differences in any of the measured cytokines in the
myocardium. As examples, IL-6 (infarct area, P = 0.15; border
area P = 0.40) and IL-1b (infarct area, P = 0.9; border area
P = 0.25) concentrations are shown in Figure 5A and B. Similarly,
we did not observe any significant difference between open and
closed chest procedure animals regarding neutrophil and macro-
phage numbers in the myocardium 72 hrs after reperfusion
(Fig. 5C–F). Finally, we determined cardiomyocyte apoptosis
72 hrs after reperfusion. There were no significant differences
between the open chest and closed chest group in caspase-3 posi-
tive cells (Fig. 5G and H).
As bradykinin has previously been reported to mediate the cardio-
protective effects of abdominal skin incision on reperfusion injury, we
measured the bradykinin precursor HMWK. High molecular weight
kininogen fragmentation serves as a proxy for bradykinin, with low
HMWK levels reflecting fragmentation and high bradykinin release.
Compared to baseline, absolute HMWK concentrations were higher in
the closed chest compared to the open chest group (P = 0.043) and
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Fig. 3 LV function was measured 72 hrs after reperfusion. (A) End diastolic volume was not significantly lower in pigs subjected to medial ster-
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a trend was observed for relative expression levels between groups
(P = 0.095), indicating that bradykinin release was higher in the open
chest group (Fig. 5I and J).
Discussion
For the development and validation of novel cardioprotective strate-
gies aiming at reduced ischemia reperfusion injury, new compounds
need to be tested in models that resemble the clinical situation as clo-
sely as possible [7, 26]. This study indicates that medial sternotomy
reduces IS and preserves cardiac function in a porcine MI model,
possibly confounding the effect of pharmacological therapies in this
model.
Our observation may partly be explained by the effect of open
chest surgery on cardiac pressure, as MAP decreased during the first
3 hrs after cardiac ischemia. Cardiac pressure analysis over time
revealed a significant decrease in load dependent dPdt-max and dPdt-
min 72 hrs after surgery despite smaller IS and better cardiac func-
tion. This indicates that sternotomy unloads the LV and this effect
was still measurable after 3 days. However, a reduction in myocardial
workload is unlikely to be the only responsible mechanism for the
observed IS reduction as previous research reported similar effects of
additional trauma on IS, which persisted after blood pressure normal-
ization by saline infusion [27].
Various small and large animal studies have shown that abdom-
inal skin injury preceding experimental MI results in reduced IS
[27, 28]. This observed reduction seems to be mediated through
nociceptive bradykinin-mediated pathways and can be abolished by
pharmacologically inhibiting these pathways [16, 17, 29, 30].
Because of its very short half-life, we were unable to detect circu-
lating bradykinin levels in this study. However, levels of the brady-
kinin precursor HMWK were significantly lower in the open chest
group compared to the closed chest group, possibly reflecting a
higher bradykinin release. This suggests that medial sternotomy
exerts its cardioprotective effects through increased bradykinin
release.
A third, potentially relevant, mechanism is the inflammatory
response after MI. Traumatic injury triggers a very complex immune
reaction [31, 32] and could therefore alter the inflammatory response
that is involved in myocardial reperfusion injury and post-MI repair.
However, the number of circulating leucocytes during reperfusion
was not decreased in the open chest group, but actually higher at
8 hrs reperfusion. Moreover, after 72 hrs, we neither observed any
significant difference in neutrophil and macrophage accumulation in
the myocardium nor myocardial cytokine content, two major determi-
nants of post-MI infarct expansion [33–35]. Furthermore, no differ-
ences in cardiomyocyte apoptosis were found between the groups.
The free radical burst that occurs within the first hours after reper-
fusion depends on the activation of inflammatory cells during reperfu-
sion in the damaged myocardium [20]. Malondialdehyde levels in
blood drawn from the coronary sinus 1 hr after reperfusion did not
differ between the open chest and closed chest group. Although this
suggests sternotomy does not significantly influence the inflamma-
tory response post-MI, decreased ex vivo cellular responsiveness that
has been observed in patients after different surgical procedures
could also play a role [21, 22, 36].
Regardless of the mechanisms at hand, possible confounders that
may obscure the effect of cardioprotective agents in studies of experi-
mental MI should be avoided as much as possible. Better clinical
resemblance of animal models will increase translational value and
improve reproducibility and translatability towards clinical application.
Mortality between the 2 groups was not significantly different.
However, this lack of statistical significance might be attributable to
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insufficient power. Mortality is an essential parameter in translational
research and survival bias could be a confounder in cardioprotection
studies that have high mortality rates. Unfortunately, the cause of the
malignant arrhythmias in the non-surviving animals remains
unknown, but something that would be worth investigating. However,
in this study we were unable to clarify this issue, as we did not store
any plasma or tissue of the animals that died before the follow-up
time was completed.
Despite our best efforts, we could not evade introducing limiting
factors ourselves. First of all, experiments were performed under gen-
eral anaesthesia, which cannot be avoided in animal models. The
anaesthetics used may have a protective effect on the myocardium,
although the IS compared to the AAR in the minimally invasive group
was reasonably high (approximately 70%). Theoretically, differences
in blood loss because of the type of intervention may affect blood
pressure and thus IS. However, blood loss in our experiments was
minimal (<200 ml) for animals with a circulating blood volume of
approximately 5 l. Furthermore, we did not find any evidence for a
modulation of myocardial inflammation by medial sternotomy, indi-
cating that the reduction in IS cannot be ascribed to this mechanism.
However, to fully conclude this, follow-up studies need to be per-
formed that specifically focus on the inflammatory response (e.g.
other leucocyte subsets, cellular responsiveness). Finally, we did not
administer any pharmacological agent to block bradykinin-mediated
pathways or pro-inflammatory pathways to conclusively determine
whether any of the two mechanisms could (partly) be held responsi-
ble for the IS reduction after medial sternotomy. Determining whether
these or other key mechanisms play a role in the reduction in IS after
medial sternotomy will allow for specifically targeting these pathways.
Pharmacological inhibitors could be developed to inhibit these newly
discovered cellular signals and determine whether the phenomenon
that we have observed in this study, can directly be translated into
clinical applications to salvage myocardium in post-MI patients. As
this was not the primary purpose of this study, and therefore remains
to be elucidated in future studies.
In conclusion, this study shows that medial sternotomy preceding
MI in a porcine model reduces IS and preserves cardiac function. As
the mechanisms responsible for this observation are not fully eluci-
dated, it remains unclear how our findings affect the outcome of car-
dioprotection studies with open chest surgery. The ever-evolving
A B C D
E F
I J
G H
Fig. 5 Local markers of the inflammatory response were measured in the myocardium. (A) Myocardial IL-6 content corrected for protein concentra-
tion in both the border and infarct zone differed non-significantly between the open chest and closed chest group. (B) Myocardial IL-1b content cor-
rected for protein concentration in both the border and infarct zone differed non-significantly between the open chest and closed chest group. (C)
Representative picture of histological section of infarcted myocardial tissue containing neutrophils (red cells) 72 hrs post-reperfusion. (D) Neutrophil
numbers in both the border and infarcted zone of the myocardium are similar between the open chest and closed chest group. (E) Representative
picture of macrophages (red) resided in the infarcted myocardium. (F) Macrophage numbers in both the border and infarcted zone of the myocar-
dium are similar between the open chest and closed group. (G) Representative picture of an active caspase-3 positive cell (red). (H) Apoptosis of
myocardial cells was similar between open chest and closed chest pigs. (I and J) Absolute and relative kininogen levels are higher in the closed
chest compared to the open chest group. pg: picogram; mg: milligram; AU: arbitrary units; CC: closed chest; OC: open chest, *P < 0.05,
**0.05 < P < 0.1.
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techniques of percutaneous coronary interventions enable animal
models to increasingly resemble the clinical situation and in combina-
tion with our results call for minimally invasive cardiac ischemia mod-
els. This may reduce the possibility of false-positive and –negative
studies and improve translational value of preclinical research.
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